Library search
How to Keep Your Company from Falling Apart: It's Your Board of Directors. Really..jpg&w=256&q=75)
1929 Crash. SEC. Bank Failures. FDIC. Savings and Loan Crisis. FIRREA. Enron/Andersen/WorldCom. SOX. Compensation Abuse. CD&A. Fannie Mae/Freddie Mac. FHFA. Lehman/AIG/Global Financial Crisis. TARP, TALF and Dodd-Frank.
See a pattern?...Read more
Mark Ohringer
Global General Counsel, Jones Lang LaSalle, USA
Head in the Clouds: Navigating the Legal Cloud Nebula
In the world of computing and technology much has happened in a short time. This is especially true with respect to the new (sort of) technology known as “cloud computing”....Read more
Joseph Bambara
Attorney at Law, WithersworldWide/UCNY, USA
Increased Evolution of Regulations Affecting the Pharmaceutical Law Practice
The increase of regulations over the last two to five years for pharmaceutical companies has become a nightmare for sales representatives working for those companies and for internal staff charged...Read more
Jean Frydman
Partner, Fox Rothschild , USA
US and International Codes on Pharmaceutical Marketing Practices and Interaction with Healthcare Professionals - A Comparative Analysis and Outlook on Harmonization by FCPA Enforcement
In recent years, there has been an increasing focus on pharmaceutical marketing practices and interactions between pharmaceutical companies and healthcare professionals. Concerns about real and perceived improprieties have led to...Read more
Roy Birnbaum
Counsel, Human Health International, Merck & Co, Inc., USA
The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective
The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more
Leslie Restaino
General Counsel, Validus Pharmaceuticals, USA
Pharmaceutical Advertising in Denmark - Where did Freedom of Expression go?
Differences in the legal approach to advertisement of pharmaceuticals still exist within the European Union even though Directive 2001/83/EC of the European Parliament and of the Council of 6 November...Read more
Nicolai Ellehuus
Attorney-at-Law, Novo Nordisk Inc, USA
Legal Issues Raised by the Collection of Electronically Stored Information in Russia and China
Collections of electronically stored information (“ESI”) around the world often implicate local law including restrictions protecting the privacy rights of the individuals from whom data is collected. Collections of ESI...Read more
Patrick Zeller
Vice President & Deputy General Counsel, Guidance Software, USA
Patrick Burke
Assistant General Counsel, Guidance Software, USA
Navigating the Turbulent Seas of 21st Century Markets in a 20th Century Boat: How to Keep the Winds of Regulation from Creating a Perfect Storm.
If regulation is the raison d’être of the regulatory counsel, then positive regulatory change is its joie de vivre. In fact, deregulation to a regulatory counsel is somewhat like a...Read more
Harisha Bastiampillai
Senior Attorney, Tata Communications International Pte, USA
Patent Reform: How do we cross the finish line?
Over the last several years, widespread abuse of patent litigation has imposed a severe tax on domestic and international companies. A disproportionate amount of this tax is born by high...Read more
Jeremiah Chan
Legal Director, Google Inc., USA
Matt Fawcett
Senior Vice President General Counsel and Secretary, Network Appliance Inc, USA
The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward
In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials...Read more
Marc Wilenzick
Chief Compliance Counsel, R&D, Pfizer Inc, USA
Justin McCarthy
SVP Global Policy and International Public Affairs, Pfizer Inc., USA
Cara Cuenot
Lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA